I. Hanning

1.2k total citations
33 papers, 967 citations indexed

About

I. Hanning is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, I. Hanning has authored 33 papers receiving a total of 967 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Molecular Biology and 9 papers in Surgery. Recurrent topics in I. Hanning's work include Diabetes Management and Research (11 papers), Pancreatic function and diabetes (9 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (7 papers). I. Hanning is often cited by papers focused on Diabetes Management and Research (11 papers), Pancreatic function and diabetes (9 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (7 papers). I. Hanning collaborates with scholars based in United Kingdom, Denmark and Australia. I. Hanning's co-authors include K. G. M. M. Alberti, Philip Home, K. G. M. M. Alberti, N. W. Read, P. D. Home, A M Holgate, Alice J. Francis, J. H. B. Scarpello, Ian T. Johnson and N. A. Blackburn and has published in prestigious journals such as Diabetes Care, PEDIATRICS and Diabetologia.

In The Last Decade

I. Hanning

33 papers receiving 891 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I. Hanning United Kingdom 16 497 243 197 194 174 33 967
R. W. Simpson United Kingdom 14 483 1.0× 134 0.6× 101 0.5× 322 1.7× 236 1.4× 23 1.1k
Sydney A. Westphal United States 13 396 0.8× 157 0.6× 127 0.6× 316 1.6× 144 0.8× 35 842
M. Elizabeth Tejero Mexico 16 165 0.3× 163 0.7× 142 0.7× 225 1.2× 83 0.5× 50 849
Richard F. Harty United States 18 158 0.3× 374 1.5× 147 0.7× 149 0.8× 195 1.1× 72 1.2k
L. H. Krut South Africa 14 113 0.2× 153 0.6× 59 0.3× 144 0.7× 164 0.9× 33 668
Ian L. MacGregor United States 12 185 0.4× 370 1.5× 51 0.3× 312 1.6× 155 0.9× 20 932
Ali Tavakkolizadeh United States 22 221 0.4× 650 2.7× 68 0.3× 324 1.7× 215 1.2× 50 1.3k
Hiroo Naito Japan 17 92 0.2× 490 2.0× 160 0.8× 118 0.6× 69 0.4× 91 1.1k
Simon Dunmore United Kingdom 15 178 0.4× 226 0.9× 90 0.5× 281 1.4× 70 0.4× 32 922
Hasan Önal Türkiye 16 138 0.3× 79 0.3× 100 0.5× 87 0.4× 55 0.3× 64 644

Countries citing papers authored by I. Hanning

Since Specialization
Citations

This map shows the geographic impact of I. Hanning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Hanning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Hanning more than expected).

Fields of papers citing papers by I. Hanning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Hanning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Hanning. The network helps show where I. Hanning may publish in the future.

Co-authorship network of co-authors of I. Hanning

This figure shows the co-authorship network connecting the top 25 collaborators of I. Hanning. A scholar is included among the top collaborators of I. Hanning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Hanning. I. Hanning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shah, Parin, Pierpaolo Pellicori, I. Hanning, et al.. (2021). The effect of digoxin on renal function in patients with heart failure. BMC Nephrology. 22(1). 349–349. 3 indexed citations
2.
Pickering, A, et al.. (2008). Emergency department measurement of urinary S100B in children following head injury: can extracranial injury confound findings?. Emergency Medicine Journal. 25(2). 88–89. 14 indexed citations
3.
Windram, Jonathan, et al.. (2007). Relationship of high-sensitivity C-reactive protein to prognosis and other prognostic markers in outpatients with heart failure. American Heart Journal. 153(6). 1048–1055. 83 indexed citations
4.
Hanning, I., et al.. (2000). A Model for a Multicentre Approach to the Derivation of Reference Intervals for Thyroid Hormones and Testosterone for Laboratories Using Identical Analysers. Clinical Chemistry and Laboratory Medicine (CCLM). 38(10). 1013–1019. 16 indexed citations
5.
Seth, J., et al.. (1991). External quality assessment of immunoassays of peptide hormones and tumour markers: principles and practice.. PubMed. 27(3). 443–52. 12 indexed citations
6.
Davis, Stephen N., Peter C. Butler, Stephen Beer, et al.. (1991). The effects of human proinsulin on glucose turnover and intermediary metabolism. Metabolism. 40(9). 953–961. 8 indexed citations
8.
10.
Smith, W. G. J., I. Hanning, Desmond G. Johnston, & C. B. Brown. (1988). Pancreatic Beta-cell Function in CAPD. Nephrology Dialysis Transplantation. 3(4). 448–452. 1 indexed citations
11.
Seth, J., et al.. (1988). Quality of Performance of Assays for Maternal Serum Alphafetoprotein in the United Kingdom: Evidence from the UK External Quality Assessment Scheme 1980–87. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 25(3). 310–318. 4 indexed citations
12.
Andronikou, Styliani & I. Hanning. (1987). Parenteral Nutrition Effect on Serum Insulin in the Preterm Infant. PEDIATRICS. 80(5). 693–697. 14 indexed citations
13.
Pernet, A, et al.. (1986). The metabolic response to insulin deprivation in idiopathic brittle diabetes.. PubMed. 3(4). 193–8. 5 indexed citations
15.
Francis, Alice J., I. Hanning, & K. G. M. M. Alberti. (1985). The influence of insulin antibody levels on the plasma profiles and action of subcutaneously injected human and bovine short acting insulins. Diabetologia. 28(6). 330–4. 23 indexed citations
16.
Ørskov, Hans, et al.. (1985). A comparison of 3 methods for assessing insulin sensitivity in subjects with normal and abnormal glucose tolerance.. PubMed. 2(3). 113–20. 35 indexed citations
17.
Reeves, W G, David P. Barr, K. Gelsthorpe, et al.. (1984). Factors governing the human immune response to injected insulin. Diabetologia. 26(4). 266–71. 30 indexed citations
18.
Francis, Alice J., Philip Home, I. Hanning, K. G. M. M. Alberti, & W. M. G. Tunbridge. (1983). Intermediate acting insulin given at bedtime: effect on blood glucose concentrations before and after breakfast.. BMJ. 286(6372). 1173–1176. 51 indexed citations
19.
McCulloch, A. J., P. D. Home, R.J. Heine, et al.. (1983). INSULIN SENSITIVITY IN HYPERTHYROIDISM: MEASUREMENT BY THE GLUCOSE CLAMP TECHNIQUE. Clinical Endocrinology. 18(4). 327–333. 21 indexed citations
20.
Francis, Alice J., P. D. Home, I. Hanning, & W. M. G. Tunbridge. (1982). Intermediate acting insulin at bedtime may improve nocturnal diabetic control and reduce post breakfast hyper glycemia. Diabetologia. 23(2). 167. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026